Drugs / ammonium tetrathiomolybdate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00560495 | May 2007 → Jul 2008 | lung cancer | Roswell Park Cancer Institute | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ammonium tetrathiomolybdate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00560495 ↗ |
| Route | Oral | “Patients receive oral ammonium tetrathiomolybdate” NCT00560495 ↗ |